S J van Deventer

10.5k citations

80 papers · 8.1k indexed · 2 hit papers · h-index 42

Genetics top 0.5%
Epidemiology top 1%
Surgery top 1%
Immunology top 1%
Oncology top 2%

Co-authors: Tom van der Poll Jaap Stoker Johannes B. Reitsma Patrick M. Bossuyt J W ten Cate Evelien Dekker Jeroen C. van Rijn J. Jansen
Topics: Inflammatory Bowel Disease (19 papers)Immune Response and Inflammation (19 papers)Microscopic Colitis (9 papers)
Cited by: Immunology Genetics Epidemiology
Journals: New England Journal of Medicine Nucleic Acids Research Circulation
Partner nations: Netherlands Russia United States

In The Last Decade

S J van Deventer

80 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

2004 1.6k citations Bruce E. Sands, Frank Anderson et al. New England Journal of Medicine profile →
Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review

2006 967 citations Jeroen C. van Rijn, Johannes B. Reitsma et al. The American Journal of Gastroenterology profile →

Peers

Countries citing papers authored by S J van Deventer

Since Specialization

Citations

This map shows the geographic impact of S J van Deventer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S J van Deventer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S J van Deventer more than expected).

Fields of papers citing papers by S J van Deventer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S J van Deventer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S J van Deventer. The network helps show where S J van Deventer may publish in the future.

Co-authorship network of co-authors of S J van Deventer

This figure shows the co-authorship network connecting the top 25 collaborators of S J van Deventer. A scholar is included among the top collaborators of S J van Deventer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S J van Deventer. S J van Deventer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery 2020 ·Gene Therapy ·(unknown),Raygene Martier,(unknown),Jolanda M.P. Liefhebber,Cynthia Brouwers,Stephan M. Pouw,(unknown),Jacek Lubelski,Harald Petry,Gerard J.M. Martens,S J van Deventer,Pavlina Konstantinova,Bas Blits	26
2	Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates 2019 ·Blood Advances ·(unknown),Karin L. Kwikkers,Nerea Zabaleta,(unknown),Harald Petry,S J van Deventer,Gloria González‐Aseguinolaza,Valérie Ferreira	43
3	AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington’s Disease Minipig Model 2018 ·Molecular Therapy ·Melvin M. Evers,Jana Miniarikova,Štefan Juhás,Astrid Vallès,(unknown),Jana Juhásová,Helena Kupcová Skalníková,Petr Vodička,(unknown),Cynthia Brouwers,Bas Blits,Jacek Lubelski,Hana Kovářová,Zdeňka Ellederová,S J van Deventer,Harald Petry,Jan Motlík,Pavlina Konstantinova	122
4	Murine CD4+CD25- cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivo 2012 ·BMC Gastroenterology ·(unknown),Sander van der Marel,Anje A. te Velde,Sybren L. Meijer,Harald Petry,S J van Deventer,Valérie Ferreira	11
5	Abstract 2093: AAV1-LPLS447X Gene Therapy With Alipogene Tiparvovec Prevents Pancreatitis in Lipoprotein Lipase Deficiency 2009 ·Circulation ·Remco Franssen,Daniel Gaudet,Erik S.G. Stroes,John J.P. Kastelein,Diane Brisson,Sophie Rousseau,J. de Wal,S J van Deventer	1
6	A Double-blind, Placebo-controlled, Randomized Study of Infliximab in Primary Sclerosing Cholangitis 2008 ·Journal of Clinical Gastroenterology ·Daan W. Hommes,Willemien Erkelens,Cyriel Y. Ponsioen,Pieter Stokkers,(unknown),(unknown),Fiebo ten Kate,S J van Deventer	87
7	Muramyl dipeptide–induced differential gene expression in NOD2 mutant and wild-type crohnʼs disease patient–derived dendritic cells 2007 ·Inflammatory Bowel Diseases ·Zuzana Zelinková,Astrid J. van Beelen,Floor de Kort,Perry D. Moerland,Emiel Ver Loren van Themaat,Anje A. te Velde,S J van Deventer,Esther C. de Jong,Daniël W. Hommes	11
8	Abstract 1497: Enhanced atherogenesis and altered High Density Lipoprotein in patients with Crohn's Disease 2006 ·Circulation ·Sander I. van Leuven,(unknown),(unknown),S J van Deventer,John J.P. Kastelein,Erik S.G. Stroes,Eric de Groot,Daan W. Hommes	1
9	Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Reviewbreakdown → 2006 ·The American Journal of Gastroenterology ·Jeroen C. van Rijn,Johannes B. Reitsma,Jaap Stoker,Patrick M. Bossuyt,S J van Deventer,Evelien Dekker	967
10	Infliximab Maintenance Therapy for Fistulizing Crohn's Diseasebreakdown → 2004 ·New England Journal of Medicine ·Bruce E. Sands,Frank Anderson,Çharles N. Bernstein,William Y. Chey,Brian G. Feagan,Richard N. Fedorak,Michael A. Kamm,Joshua R. Korzenik,Bret A. Lashner,Jane E. Onken,Daniel Rachmilewitz,Paul Rutgeerts,Gary Wild,Douglas C. Wolf,P Marsters,Suzanne Travers,Marion Blank,S J van Deventer	1607
11	Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice1 1The authors thank Prof. Yvette van Kooyk, Department of Molecular Cell Biology, Free University, Amsterdam, for her gift of blocking antibodies; Drs. Formijn van Hemert and Cynara Veeris, Department of Nuclear Medicine, Academic Medical Center, Amsterdam, for their assistance in the gastric emptying studies; and Dr. Jan M. Ruijter, Department of Anatomy and Embryology, Academic Medical Center, Amsterdam, for statistical assistance. 2003 ·Gastroenterology ·Wouter J. de Jonge,René M. van den Wijngaard,Frans Olivier The,(unknown),Roel J. Bennink,Guido N.J. Tytgat,Ruud M. Buijs,Pieter H. Reitsma,S J van Deventer,Guy E. Boeckxstaens	166
12	A Prospective Randomized Study of Hydrophilic Polymer-Coated Polyurethane Versus Polyethylene Stents in Distal Malignant Biliary Obstruction 2003 ·Endoscopy ·A.M. van Berkel,MJ Bruno,JJGHM Bergman,S J van Deventer,G. N. J. Tytgat,K. Huibregtse	39
13	Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. 1997 ·Gut ·John Meenan,(unknown),(unknown),Steven T. Pals,G. N. J. Tytgat,S J van Deventer	89
14	Mechanisms underlying neutrophil adhesion to apical epithelial membranes. 1996 ·Gut ·John Meenan,Marcel L.C.M. Mevissen,Houshang Monajemi,Sandra A. Radema,Howard R. Soule,Matthew Moyle,G. N. J. Tytgat,S J van Deventer	16
15	Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation. 1996 ·Gut ·Daniël W. Hommes,John Meenan,Masja de Haas,Fiebo J. ten Kate,A E von dem Borne,G. N. J. Tytgat,S J van Deventer	38
16	Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. 1996 ·The Journal of Experimental Medicine ·Dasja Pajkrt,Doran Je,Frank Köster,P. Lerch,(unknown),Tom van der Poll,J W ten Cate,S J van Deventer	327
17	Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. 1994 ·Journal of Clinical Investigation ·Marcel Levi,Hugo Ten Cate,KA Bauer,Tom van der Poll,Thomas S. Edgington,Harry R. Büller,S J van Deventer,C. Erik Hack,J W ten Cate,R D Rosenberg	317
18	Polarised interleukin 8 secretion by HT 29/19A cells. 1994 ·Gut ·Karen M. Lammers,J. Jansen,P. B. Bijlsma,M. Ceska,G. N. J. Tytgat,Christian Laboisse,S J van Deventer	36
19	Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. 1994 ·The Journal of Experimental Medicine ·Tom van der Poll,Marcel Levi,C.E. Hack,Hugo Ten Cate,S J van Deventer,A. J. M. Eerenberg,E R de Groot,J. Jansen,H. Gallati,Harry R. Büller	302
20	Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. 1994 ·The Journal of Experimental Medicine ·Tom van der Poll,J. Jansen,Marcel Levi,Hugo Ten Cate,J W ten Cate,S J van Deventer	160

About S J van Deventer

S J van Deventer is a scholar working on Immunology, Genetics and Epidemiology, having authored 80 papers that have together received 8.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (19 papers), Immune Response and Inflammation (19 papers) and Microscopic Colitis (9 papers). The work is most often cited by research in Immunology (2.0k citations), Genetics (2.5k citations) and Epidemiology (2.3k citations). S J van Deventer has collaborated with scholars based in Netherlands, Russia and United States. Frequent co-authors include Tom van der Poll, Jaap Stoker, Johannes B. Reitsma, Patrick M. Bossuyt, J W ten Cate, Evelien Dekker, Jeroen C. van Rijn, J. Jansen, Marcel Levi and Hugo Ten Cate. Their work appears in journals such as New England Journal of Medicine, Nucleic Acids Research and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact